EGFR and non-small cell lung carcinoma: In this study, we systematically dissect the nexus between chromatin dynamics and transcriptional reprogramming using an osimertinib-resistant NSCLC model replicating key cellular and molecular features of EGFR-TKI-resistant tumors [51–53].